The development of drug resistance is a challenge for the use of adjuvant therapies in breast cancer patients [69], and studies suggest that ROS may play an important role in the production of drug-resistant cells [70]
Common side effects of adalimumab include: Injection site reactions (redness, rash, swelling, itching or bruising) Upper respiratory infections (sinus infections) Headaches Rashes Nausea There is an increased chance of getting lymphoma or other cancers in people who take TNF blockers such as adalimumab
Epstein Barr virus-positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo
Convenience is the absolute primary driver and systemic effects are a secondary, or even non-existent, concern
J Biol Chem (1948) 174:55564
*%RDA - recommended daily allowance Drink 1/2 of the ampoule (12,5 ml) two times a day approx